Company intelligence / Profile preview

Rivalesa

Ownership: Private
Development stage: Other

Overview

RIVAL is a specialized software platform designed to support pharmaceutical and biotech companies in valuing pipeline assets, modeling licensing deal terms, performing sensitivity analyses on key value drivers, and managing portfolio value. It provides industry benchmarking data and visualization tools to help stakeholders make informed business decisions. The platform has been used by over 450 clients supporting more than $10 billion in deal value.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Works with executives from top-tier companies such as Roche, Novartis, Bristol Myers Squibb, Novo Nordisk

Beyond the preview

Go deeper on Rivalesa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rivalesa.

Explore the full profile